HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.

AuthorsAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Hikaru Hori, Nobuhisa Ueda, Jun Nakamura
JournalPsychiatry and clinical neurosciences (Psychiatry Clin Neurosci) Vol. 61 Issue 4 Pg. 452 (Aug 2007) ISSN: 1323-1316 [Print] Australia
PMID17610677 (Publication Type: Letter)
Chemical References
  • Antidepressive Agents, Second-Generation
  • Fluvoxamine
Topics
  • Adolescent
  • Adult
  • Antidepressive Agents, Second-Generation (administration & dosage, blood, therapeutic use)
  • Bulimia Nervosa (drug therapy, psychology)
  • Depression (complications, psychology)
  • Drug Monitoring
  • Female
  • Fluvoxamine (administration & dosage, blood, therapeutic use)
  • Humans
  • Psychiatric Status Rating Scales

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: